These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 95055)

  • 1. [Cutaneous reactions to thiacetazone (TB1) (author's transl)].
    Strobel M; Ndiaye B; Marchand JP; Jovet JC
    Rev Fr Mal Respir; 1979; 7(5):467-70. PubMed ID: 95055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thiacetazone toxicity in the treatment of tuberculosis patients in Nigeria.
    Pearson CA
    J Trop Med Hyg; 1978 Dec; 81(12):238-42. PubMed ID: 85717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe cutaneous hypersensitivity reactions during treatment of tuberculosis in patients with HIV infection in Tanzania.
    Dukes CS; Sugarman J; Cegielski JP; Lallinger GJ; Mwakyusa DH
    Trop Geogr Med; 1992 Oct; 44(4):308-11. PubMed ID: 1284179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Skin toxicity of thiacetazone (TB1) at a hospital service in Dakar].
    Dieng MT; Ndiaye B; Camara C
    Dakar Med; 2001; 46(1):1-3. PubMed ID: 15773145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse cutaneous reactions to thiacetazone for tuberculosis treatment in Tanzania.
    Ipuge YA; Rieder HL; Enarson DA
    Lancet; 1995 Sep; 346(8976):657-60. PubMed ID: 7544858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Life-threatening cutaneous reactions to thiacetazone-containing antituberculosis treatment in Kumasi, Ghana.
    Lawn SD; Frimpong EH; Acheampong JW
    West Afr J Med; 1999; 18(4):249-53. PubMed ID: 10734785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in human immunodeficiency virus infected adults.
    Okwera A; Johnson JL; Vjecha MJ; Wolski K; Whalen CC; Hom D; Huebner R; Mugerwa RD; Ellner JJ
    Int J Tuberc Lung Dis; 1997 Oct; 1(5):441-5. PubMed ID: 9441099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cutaneous reaction to thiacetazone (TB1) (apropos of 8 cases)].
    Strobel M; Ndiaye B; Jovet JC; Marchand JP
    Dakar Med; 1980; 25(2):125-30. PubMed ID: 6163598
    [No Abstract]   [Full Text] [Related]  

  • 9. [Severe skin eruptions caused by thioacetazon in the treatment of tuberculosis in the state of Rio Grande do Sul, Brazil. Secretary of Health of the State of Rio Grande do Sul].
    Bol Oficina Sanit Panam; 1981 Jan; 90(1):10-18. PubMed ID: 6163442
    [No Abstract]   [Full Text] [Related]  

  • 10. HIV seroprevalence rate and incidence of adverse skin reactions in adults with pulmonary tuberculosis receiving thiacetazone free anti-tuberculosis treatment in Yaounde, Cameroon.
    Kuaban C; Bercion R; Koulla-Shiro S
    East Afr Med J; 1997 Aug; 74(8):474-7. PubMed ID: 9487410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe cutaneous eruptions caused by thiacetazone used to treat tuberculosis in Rio Grande do Sul, Brazil. Public Health Dermatology Team, Tuberculosis Team, and Epidemiologic Control Unit, Rio Grande do Sul State Department of Health.
    Bull Pan Am Health Organ; 1981; 15(2):113-20. PubMed ID: 6173089
    [No Abstract]   [Full Text] [Related]  

  • 12. Cutaneous hypersensitivity reactions due to thiacetazone in the treatment of tuberculosis in Zambian children infected with HIV-I.
    Chintu C; Luo C; Bhat G; Raviglione M; DuPont H; Zumla A
    Arch Dis Child; 1993 May; 68(5):665-8. PubMed ID: 7686737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A thiacetazone toxicity trial in Sarawak.
    Webb AH
    N Z Med J; 1973 Nov; 78(502):490-12. PubMed ID: 4129254
    [No Abstract]   [Full Text] [Related]  

  • 14. Coexistence of fixed drug eruptions and Stevens Johnson syndrome due to thiacetazone in a patient of pulmonary tuberculosis.
    Gupta PK; Luniya AK; Gupta NK; Tiwari ML
    Indian J Chest Dis Allied Sci; 1983; 25(2):152-4. PubMed ID: 6197367
    [No Abstract]   [Full Text] [Related]  

  • 15. Concurrent comparison of an unsupervised daily oral regimen of thiacetazone plus isoniazid and a fully supervised twice-weekly regimen of streptomycin plus isoniazid in the domiciliary treatment of pulmonary tuberculosis--a co-operative investigation.
    Menon K
    Bull Int Union Tuberc; 1974 Aug; 49 suppl 1():131-2. PubMed ID: 4143180
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thiacetazone (Tb-1): recent experimental and clinical data].
    Grosset J; Benhassine M
    Bibl Tuberc; 1970; 26():107-53. PubMed ID: 4189928
    [No Abstract]   [Full Text] [Related]  

  • 17. A study of adverse reactions to high dosage intermittent thiacetazone.
    Fox W; Stark AJ; Tall R; Bhatia JL; Clarke JH; Donia TO; Krishnaswami KV; Oussedik N
    Tubercle; 1974 Mar; 55(1):29-40. PubMed ID: 4143448
    [No Abstract]   [Full Text] [Related]  

  • 18. A controlled study on progressive primary pulmonary tuberculosis in children treated for one year with dual drugs: streptomycin and isoniazid versus isoniazid and thiacetazone.
    Gupta SK; Law SC
    J Indian Med Assoc; 1972 Dec; 59(11):463-7. PubMed ID: 4120719
    [No Abstract]   [Full Text] [Related]  

  • 19. Three initial streptomycin supplements to standard isoniazid-thiacetazone chemotherapy. East African-British Medical Research Council investigation.
    Kent PW
    Bull Int Union Tuberc; 1970 Jun; 43():256-60. PubMed ID: 4193294
    [No Abstract]   [Full Text] [Related]  

  • 20. Dermatological hypersensitivity to thiacetazone.
    Ravindran P; Joshi M
    Indian J Chest Dis; 1974 Jan; 16(1):58-60. PubMed ID: 4138156
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.